摘要
目的研究基质细胞衍生因子(SDF-1)在多发性骨髓瘤(MM)细胞迁移、黏附中的生物学作用以及相关信号转导。方法采用流式细胞术检测 MM 细胞系 RPMI8226、XG-1、XG-7细胞黏附分子表达;免疫荧光技术检测 SDF-1对细胞形态以及膜表面黏附分子分布的影响;通过微孔隔离实验检测 SDF-1对 MM 细胞的趋化作用及磷脂酰肌醇3激酶(PI3K)在趋化过程中的作用;免疫印迹技术检测 MM 细胞 SDF-1对 PI3K的活化。结果 3种 MM 细胞系不同程度表达多种黏附分子,RPMI8226、XG-7细胞均高表达黏附分子 CD29(>70%)、XG-1、XG-7细胞均高表达 CD44(>80%),XG-7细胞高表达 CD49d(>90%);3种细胞系 CD49e 表达水平均较低(<30%);这些黏附分子表达水平不能被SDF-1α明显上调。SDF-1α可触发 MM 细胞的极化形态建立以及诱导 CD29、CD49e 在细胞膜的重分布。SDF-1α能促进 MM 细胞对内皮细胞的黏附,并能够诱导 MM 细胞的迁移,此作用被 G 蛋白抑制剂 PTX 及 PI3K 抑制剂 wortmannin 明显抑制。结论 SDF-1α促进 MM 细胞对内皮细胞的黏附;并触发MM 细胞的极化形态建立及诱导黏附分子的重分布,从而通过 PI3K 信号途径诱导 MM 细胞的迁移。
Objective To investigate the biological behavior of stromal cell-derived factor-1 (SDF-1) on multiple myeloma(MM) cell migration and adhesion and it related signaling pathways. Methods Expression of adhesion molecules on MM cells of RPMI8226,XG-1 and XG-7 cells was analysed by flow cytometry, the influence of SDF-1 on CD29 and CD49e distribution by immunofluoreseence, the effect of SDF-1 on ehemotaxis of MM cells by transwell assay. Activation of phosphoinositide-3 kinase(P13K) in MM cells treated with SDF-1 and by immunoblotting. Results 3 strains of MM cell line expressed many adhesion molecule. RPMI8226 ,XG-7 cells were all high level of expression of CD29 ( 〉70% ). XG-1, XG-7 cells were all high level of expression of CD44 ( 〉 80% ), and XG-7 cells was of CD49d ( 〉 90% ). In all of 3 strains, the levels of expression of CIM9e were low ( 〈 30% ). SDF-1 could not upregulate their expression, but could trigger the establishment of polarized morphology of MM cells and the redistribution of CD29 and CD49e. SDF-1 promoted MM cells adhesion to endothelial cells, stimulated phosphorylation of P85 subunit of PI3K in MM cells and induced MM cells migration,which were inhibited by G protein inhibitor PTX and PI3K inhibitor wortmannin. Conclusion SDF-1 can promote MM cell adhesion to endothelial cells, trigger establishment of a polarized morphology of MM cells and redistribution of adhesion molecules and induce MM cells migration via PI3K signaling pathway.
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2006年第4期240-243,共4页
Chinese Journal of Hematology
基金
江苏省135重点医学人才基金(RC2002021)